The promise of cord blood
Researchers are using donated cord blood to conduct extensive medical research. The results have been striking — many specialists believe the potential of cord blood stem cells is limitless.
Perhaps the most promising area of research is regenerating damaged tissues and organs with cord blood. Regenerative medicine encompasses a number of innovative medical therapies that will enable the body to repair, replace, restore and regenerate damaged or diseased cells, tissues and organs. Cord blood stem cells are proving to have remarkable regenerative properties.
Currently, landmark trials are underway in regenerative medicine that are investigating treatments for diseases like juvenile diabetes and cerebral palsy using autologous transplants, or one’s own cord blood stem cells. Early results have been promising, and final results from these clinical trials are expected to generate more interest in cord blood stem cell treatments for a number of diseases.
Brain injury
Stem cells from a child’s own umbilical cord are expected to bring about improved outcomes for anoxic brain injury at birth, cerebral palsy, and traumatic brain injury. Watch one child’s story here.
Juvenile diabetes
Studies being conducted among children with this disease are finding improved insulin production through treatment with autologous transplants.
Heart disease
Results from a 2005 study suggest the potential for cord blood stem cells to improve outcomes in human patients following heart attack.
Corneal regeneration
Cord blood stem cells could provide a future therapeutic option for individuals with disorders of the ocular surface, according to recent studies.
Other diseases and conditions cord blood stem cells have shown the potential to cure or treat are:
- Alzheimer’s disease
- Lupus
- Multiple sclerosis
- Muscular dystrophy
- Parkinson’s disease
- Rheumatoid arthritis
- Spinal cord injury
- Stroke
- Liver disease
More information on current research is available at:
American Association of Blood Banks
National Cord Blood Program
